Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy (REBT)
Phase 3 Study of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy
Sponsor: Seoul National University Bundang Hospital
A PHASE3 clinical study on Goiter and Thyroid Neoplasm, this trial is completed. The trial is conducted by Seoul National University Bundang Hospital and has accumulated 13 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 8 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Nov 2020 [monthly]
Completed PHASE3
-
May 2018 — Jun 2018 [monthly]
Completed PHASE3
-
Sep 2017 — May 2018 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Feb 2017 — Sep 2017 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Seoul National University Bundang Hospital
- Seoul National University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .